MEDPAL AI is trading at £4.00, up 5.26%, amid healthcare-sector strength.
- No fresh company-specific announcement was identified for August 20, 2026; the latest listed RNS was August 11.
- XLV was reported up 3.23%, supported by earnings optimism, regulatory conditions, healthcare M&A, and investor rotation.
- MedPal AI’s earlier August 4 trading update showed annualised recurring revenue above £8.6 million, but that catalyst is stale.